CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net loss	$ (38,539,436)	$ (32,146,057)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	1,737,077	1,319,003
Impairment of goodwill	0	5,210,821
Impairment of indefinite-lived intangible assets	4,000,000	0
Interest paid on the conversion of debt to equity		21,274
Warrants issued for services		23,894
Loss on extinguishment of debt	4,940,911	544,444
Amortization of operating lease right-of-use-assets	191,133
Stock-based compensation	2,988,544	2,023,874
Issuance of common stock in exchange for services	140,000	6,425
Issuance of common stock in Tempesta settlement agreement	48,800
Tempesta settlement note expense	550,000
Amortization of debt issuance costs and debt discount	5,157,338	1,196,914
Change in fair value of warrants, conversion option and derivative liability	(1,009,402)	(6,325)
Changes in assets and liabilities
Accounts receivable	(696,028)	(528,025)
Other receivable	(7,850)	(4,738)
Inventory	1,213,492	(1,269,360)
Prepaid expenses and other current assets	(246,658)	(111,616)
Other non-current assets	108,687	(262,659)
Deferred collaboration revenue		(177,389)
Operating lease liabilities	(132,985)	109,240
Deferred rent	221,692
Accounts payable	(62,725)	(1,940,671)
Accrued expenses	(1,059,396)	3,260,119
Total cash used in operating activities	(20,456,806)	(22,730,832)
Cash flows from investing activities
Purchase of equipment		(6,527)
Total cash used in investing activities		(6,527)
Cash flows from financing activities
Proceeds from issuance of notes payable	5,050,000	2,564,938
Proceeds from issuance of convertible debt		474,000
Repayment of notes payable	(5,150,000)	(1,689,200)
Repayment of convertible debt		(566,249)
Proceeds from issuance of common stock	2,249,100	7,055,874
Payment of underwriting discounts, commissions and other associated offering costs		(2,117,550)
Fractional common shares repurchased		(30)
Total cash provided by financing activities	21,771,993	24,545,683
Net increase in cash	1,315,187	1,808,324
Cash at beginning of year	2,568,191	759,867
Cash at end of year	3,883,378	2,568,191
Supplemental disclosure of cash flow information
Cash paid for interest	142,000
Supplemental schedule of non-cash financing and investing activities
Common stock issued in exchange for CVP Exchange Note 1 principal and related interest	6,672,838
Common stock issued in payment of accrued interest on Kingdon notes payable	446,729
Accretion to redemption value of Series A contingently redeemable convertible preferred stock	894,490
September 2018 L2 convertible note payable
Supplemental schedule of non-cash financing and investing activities
Common stock issued as redemption of notes payable and related interest		48,000
Common stock issued in payment of CVP Note Payable principal and related interest	8,224,923
Private Investment in Public Entities March 2018
Cash flows from financing activities
Proceeds from the issuance of convertible preferred stock, March 2018		9,199,002
Private Investment in Public Entities July 2018
Cash flows from financing activities
Proceeds from issuance of common stock		624,897
Private investment in public entities, October 2018
Cash flows from financing activities
Proceeds from issuance of common stock		6,945,000
Supplemental schedule of non-cash financing and investing activities
Issuance of warrants		611,286
Private Investment In Public Entities November 2019 Offering [Member]
Cash flows from financing activities
Payment of underwriting discounts, commissions and other associated offering costs	(64,503)
Equity Forward Contracts October 2018
Cash flows from financing activities
Proceeds from issuance of common stock		2,055,001
Jaguar Notes Payable
Supplemental schedule of non-cash financing and investing activities
Interest paid on long-term debt		19,344
Common stock issued as redemption of notes payable and related interest		1,153,408
Napo convertible debt
Supplemental schedule of non-cash financing and investing activities
Common stock issued as redemption of notes payable and related interest		1,638,546
PIPE Financing warrants, Dec 2019
Cash flows from financing activities
Proceeds from Issuance of Warrants	1,500,000
Proceeds from issuance of convertible preferred stock	1,500,000
Series 2 warrants | Private Investment in Public Entities July 2019
Cash flows from financing activities
Proceeds from issuance of convertible preferred stock	5,025,515
LOC warrant
Supplemental schedule of non-cash financing and investing activities
Issuance of warrants	71,079
Reclassification of warrants from liability to equity	71,079
Bridge Note Warrants
Supplemental schedule of non-cash financing and investing activities
Reclassification of warrants from liability to equity	4,259,327
Series 1 warrants
Cash flows from financing activities
Proceeds from Issuance of Warrants	1,750,001
Supplemental schedule of non-cash financing and investing activities
Deemed dividend	522,143
Series 1 warrants | Private Investment in Public Entities July 2019
Cash flows from financing activities
Proceeds from Issuance of Warrants	5,025,515
Series 1 Warrants via Put option Oct 2019
Cash flows from financing activities
Proceeds from Issuance of Warrants	1,750,001
Pre-funded Warrants | Private Investment In Public Entities November 2019 Offering [Member]
Cash flows from financing activities
Proceeds from issuance of common stock	64,503
Common Stock To Oasis Put Exercise
Cash flows from financing activities
Proceeds from issuance of common stock	2,612,756
Common Stock To Oasis Registered Offering
Cash flows from financing activities
Proceeds from issuance of common stock	266,266
Series B convertible preferred stock
Cash flows from financing activities
Payment of underwriting discounts, commissions and other associated offering costs	(875,184)
Supplemental schedule of non-cash financing and investing activities
Deemed dividend	4,239,870
Common stock issued upon conversion of Series B convertible preferred stock	2,128,317
Series A convertible preferred stock
Supplemental schedule of non-cash financing and investing activities
Accretion to redemption value of Series A contingently redeemable convertible preferred stock	(894,490)
Series A convertible preferred stock | September 2018 L2 convertible note payable
Supplemental schedule of non-cash financing and investing activities
Issuance of warrants		118,148
Series A convertible preferred stock | Series 1 warrants
Supplemental schedule of non-cash financing and investing activities
Deemed dividend		$ 995,000
Series B-2 convertible preferred stock | Pre-funded Warrants | Private Investment In Public Entities November 2019 Offering [Member]
Cash flows from financing activities
Proceeds from issuance of convertible preferred stock	1,777,778
Class A units
Cash flows from financing activities
Payment of underwriting discounts, commissions and other associated offering costs	(875,122)
Class B units
Cash flows from financing activities
Payment of underwriting discounts, commissions and other associated offering costs	(1,635,183)
Class B units | Private Investment in Public Entities July 2019
Cash flows from financing activities
Proceeds from the issuance of convertible preferred stock, March 2018	$ (4,239,870)